Shoddy biopsies deny cancer patients a shot at personalized treatment

Elie Dolgin • January 22, 2016

A huge federal trial of personalized cancer medicine has run into an unexpected roadblock: Many of the tumor samples aren’t robust enough to be put through genetic analysis.

Continue reading at STAT.

By Elie Dolgin July 22, 2026
But politics could derail the one thing to unlock it.
By Elie Dolgin June 11, 2026
Enhanced cryo–electron microscopy promises to bring previously elusive proteins into view.